DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» NPM1
NPM1
Parameter IV Dose (1 Mg/Kg) Oral Dose (10 Mg/Kg)
NPM1-ALK (Human) Recombinant Gene Summary: the 2;5 Chromosomal Translocation Is Protein Frequently Associated with Anaplastic Large Cell Lymphomas (Alcls)
Increased Expression of NPM1 Suppresses P27kip1 Function in Cancer Cells
Core Transcription Factors, Oct4, Sox2 and Nanog, Individually Form Complexes with Nucleophosmin (Npm1) to Control Embryonic Stem
Next Generation Gene Sequencing -Solid Tumor
Rnascope® Probes for Stem Cells Research Get Probes for Your Gene of Interest Designed and Manufactured in Two Weeks
Molecular Pathology Tests
Next-Generation Sequencing-Based Multigene Mutational Screening for Acute Myeloid Leukemia Using Miseq: Applicability for Diagnostics and Disease Monitoring
Frequency and Prognostic Value of NPM1 Mutations in Sudanese Acute Myeloid Leukemia Patients
Cancer Stem Cell Markers in Glioblastoma – an Update
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
A Novel Type of NPM1 Mutation Characterized by Multiple Internal Tandem Repeats in a Case of Cytogenetically Normal Acute Myeloi
Altered Nucleophosmin Transport in Acute Myeloid Leukaemia with Mutated NPM1: Molecular Basis and Clinical Implications
Genetic Testing Overview
Mutations of NPM1 and FLT3 and Deletion of Chromosome 5 Del(5Q
Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma With
© Ferrata Storti Foundation
The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1
Top View
Phase Separations Promoted by RNA Scaffolds and Protein Sequestration In
The Nucleolar Protein Nucleophosmin Undergoes Liquid-Liquid Phase Separation with Arginine-Rich Nucleolar Proteins Through Weak
NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
Mouse Models of NPM1-Mutated Acute Myeloid Leukemia: Biological and Clinical Implications
NPM1 Mutation Analysis Test Description 2016 03 03.Indd
Mutational Signatures in Cytogenetic Risk Groups of De Novo AML and MDS
NPM-ALK: a Driver of Lymphoma Pathogenesis and a Therapeutic Target
NPM1 Gene Nucleophosmin 1
(NPM1) Mutations and Is Restricted to AML
NPM1 Deletion Is Associated with Gross Chromosomal Rearrangements in Leukemia
The BRCA1 and BRCA2 Breast and Ovarian Cancer Susceptibility Genes — Implications for DNA Damage Response, DNA Repair and Cancer Therapy Orr, K
MDS/MPN with NPM1 Mutation
Myeloid Malignancies Mutation Panel by Next Generation Sequencing
Molecular Profiling of Chinese Systemic Anaplastic Large Cell Lymphoma Patients: Novel Evidence of Genetic Heterogeneity
Targeting Akt in Cancer for Precision Therapy Hui Hua1, Hongying Zhang2, Jingzhu Chen2, Jiao Wang3, Jieya Liu2 and Yangfu Jiang2*
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
What Is Abnormal in Normal Karyotype Acute Myeloid Leukemia in Children? Analysis of the Mutational Landscape and Prognosis of the TARGET-AML Cohort
TP-0903 Is Active in Models of Drug-Resistant Acute Myeloid Leukemia